We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SONN Sonnet BioTherapeutics Holdings Inc

0.0801 (5.34%)
After Hours
Last Updated: 18:18:25
Delayed by 15 minutes


Draw Mode:

Volume 34,364
Bid Price 1.46
Ask Price 1.59
News -
Day High 1.5797


52 Week Range


Day Low 1.49
Company Name Stock Ticker Symbol Market Type
Sonnet BioTherapeutics Holdings Inc SONN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0801 5.34% 1.58 18:18:25
Open Price Low Price High Price Close Price Prev Close
1.53 1.49 1.5797 1.57 1.4999
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
302 34,364 $ 1.54 $ 52,793 - 1.08 - 36.96
Last Trade Time Type Quantity Stock Price Currency
17:44:45 formt 450 $ 1.58 USD

Sonnet BioTherapeutics Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.75M 1.75M - 350k -29.72M -16.98 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sonnet BioTherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SONN Message Board. Create One! See More Posts on SONN Message Board See More Message Board Posts

Historical SONN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.501.69921.32021.5193,4730.085.33%
1 Month1.421.69921.181.4271,8480.1611.27%
3 Months3.803.801.081.7471,129-2.22-58.42%
6 Months9.9026.401.0812.091,368,831-8.32-84.04%
1 Year21.7836.961.0811.271,565,976-20.20-92.75%
3 Years791.561,051.821.08177.613,033,239-789.98-99.8%
5 Years1,915.764,989.601.08330.702,870,699-1,914.18-99.92%

Sonnet BioTherapeutics Description

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |